Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00400283 | A Study Looking Into the Effect of NNC 55-0414 in Subjects With Type 2 Diabetes | PHASE1 | COMPLETED | 23 | — | — | Jan 19, 2001 | May 3, 2001 | Feb 24, 2017 | 1 | Germany |
| Name | Type | Description |
|---|---|---|
| NNC 55-0414 | DRUG | - |
Inclusion Criteria: * Type 2 diabetes * Diet treatment only for at least two weeks * Body mass index (BMI) between 22-34 kg/m2 inclusive * HbA1C between 6.5-12.0% inclusive * Fasting blood glucose (FBG) between 7.0-18.0 mmol/L inclusive * Patients should be negative (lesser than 70 kU/l) for antibo...